Bio-Path Holdings, Inc. (BPTH)
OTCMKTS · Delayed Price · Currency is USD
0.0572
-0.0028 (-4.67%)
Feb 6, 2026, 9:30 AM EST
Bio-Path Holdings Market Cap
Bio-Path Holdings has a market cap or net worth of $554.53 thousand as of February 6, 2026. Its market cap has decreased by -84.71% in one year.
Market Cap
554.53K
Enterprise Value
1.03M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since February 15, 2008, Bio-Path Holdings's market cap has decreased from 31.22M to 554.53K, a decrease of -98.22%. That is a compound annual growth rate of -20.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 554.53K | - |
| Dec 31, 2025 | 554.53K | -88.90% |
| Dec 31, 2024 | 5.00M | -12.65% |
| Dec 29, 2023 | 5.72M | -52.42% |
| Dec 30, 2022 | 12.02M | -55.47% |
| Dec 31, 2021 | 26.99M | 69.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aibotics | 819.95K |
| Lipella Pharmaceuticals | 790.16K |
| Protagenic Therapeutics | 776.37K |
| SQZ Biotechnologies Company | 707.79K |
| Avenue Therapeutics | 704.23K |
| Hepion Pharmaceuticals | 662.36K |
| Helix BioMedix | 606.71K |
| Altamira Therapeutics | 601.84K |